摘要 |
The invention relates to the use of 1-oxapenem-3-carboxylic acids of the following structures …<IMAGE>… and… in which R<1> and R<2> have the meaning given in the description, as beta -lactamase inhibitors and to pharmaceutical compositions which contain the abovementioned 1-oxapenem-3-carboxylic acids and a conventional antibiotic. |